Table 1.
Baseline data of patients and tumor characteristics
| Characteristics | Value | Percentage |
|---|---|---|
| Age (years) | ||
| Median | 59 | |
| Range | 44–80 | |
| Sex | ||
| Female | 11 | 18.6 |
| Male | 48 | 81.4 |
| Tumor length (cm) | ||
| Median | 4.5 | |
| Range | 1–10 | |
| T category | ||
| T2 | 9 | 15.3 |
| T3 | 28 | 47.5 |
| T4 | 22 | 37.3 |
| Lymph node category | ||
| N1 | 37 | 62.7 |
| N2 | 13 | 22.0 |
| N3 | 9 | 15.3 |
| Tumor location | ||
| Cervical | 8 | 13.6 |
| Upper thoracic | 23 | 39.0 |
| Mid-thoracic | 17 | 28.8 |
| Lower thoracic | 11 | 18.6 |
| Chemotherapy | ||
| 5-Fu/platinum | 19 | 32.2 |
| Paclitaxel/platinum | 16 | 27.1 |
| Docetaxel/platinum | 13 | 22.0 |
| Others | 11 | 18.6 |
| Radiotherapy dose (Gy) | 50.4–68.4 |